Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;18(1):1-6.
doi: 10.5114/wo.2013.39995. Epub 2013 Dec 20.

The diagnostics of colorectal cancer

Magdalena Swiderska  1 , Barbara Choromańska  2 , Ewelina Dąbrowska  3 , Emilia Konarzewska-Duchnowska  3 , Katarzyna Choromańska  4 , Grzegorz Szczurko  5 , Piotr Myśliwiec  2 , Jacek Dadan  2 , Jerzy Robert Ladny  3 , Krzysztof Zwierz  6
Affiliations
Review

The diagnostics of colorectal cancer

Magdalena Swiderska et al. Contemp Oncol (Pozn). 2014.

Abstract

Colorectal cancer (CRC) is one of the most frequent human malignant neoplasms. CRC has an estimated incidence of more than 1,000,000 new cases annually worldwide. Approximately one out of three people who develop CRC dies from the disease. Furthermore, CRC often affects inhabitants of industrialized countries in comparison to less developed countries. Several markers of colon cancer, including CEA, CA-19-9, TPS, TAG-72 and lysosomal hydrolases, have been identified and are now being adopted in routine clinical practice. Increased values of these markers are often the first signal of recurrence or metastases, which is useful in prediction and prognosis of clinical outcome of patients with CRC. Determination of the activity of lysosomal exoglycosidases in body fluids may bring some hope of improving diagnosis of colorectal cancer. However, it has to be remembered that currently the most effective diagnostic method of CRC is endoscopy.

Keywords: colorectal cancer; endoscopy; lysosomal exoglycosidases; tumor markers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2009 roku. Warszawa: Centrum Onkologii – Instytut im. M. Skłodowskiej-Curie; 2011.
    1. Wronkowski Z, Brużewicz S. Nowotwory jelita grubego. Warszawa: Wydawnictwo Lekarskie PZWL; 2008. pp. 9–26, 44, 53-6.
    1. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem. 2006;17:145–56. - PubMed
    1. Krakowczyk Ł, Strzelczyk JK. Epigenetyczna modyfikacja ekspresji genów w rozwoju raka jelita grubego. Wspolczesna Onkol. 2007;11:289–94.
    1. Akouchekian M, Houshmand M. Mitochondrial haplogroup analysis in analysis in colorectal cancer: identification of a high-risk population. Arch Med Sci. 2008;12:397–400.